Milan, Italy

Marisa Conti


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1987-1993

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Marisa Conti: Innovator in Ophthalmic Pharmaceutical Compositions

Introduction

Marisa Conti is a distinguished inventor based in Milan, Italy. She has made significant contributions to the field of ophthalmology through her innovative pharmaceutical compositions. With a total of four patents to her name, her work focuses on novel methods for treating ocular conditions.

Latest Patents

Among her latest patents, Conti has developed methods and pharmaceutical compositions for the treatment of ophthalmic conditions using anthocyanidins, specifically pelargonidin and delphidin. These compounds have demonstrated unexpected activity in reducing the permeability of ciliary body vessels. Her invention provides a method for reducing hyperpermeability in ocular vessels by administering effective doses of these compounds. Additionally, she has created novel water-soluble derivatives of silybin, which are useful in treating liver disorders and other applications requiring an anti-radical effect. These derivatives exhibit high hydrophilicity and stability, making them superior to prior art compounds.

Career Highlights

Throughout her career, Marisa Conti has worked with notable companies such as Inverni Della Beffa Spa and IDB Holding S.p.a. Her experience in these organizations has contributed to her expertise in pharmaceutical innovations.

Collaborations

Conti has collaborated with esteemed colleagues, including Giorgio Pifferi and Raffaello Giorgi. Their joint efforts have further advanced the research and development of her innovative pharmaceutical compositions.

Conclusion

Marisa Conti's contributions to the field of ophthalmology through her patents and collaborations highlight her role as a leading inventor. Her work continues to pave the way for advancements in pharmaceutical treatments for ocular conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…